MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized plans may boost transplant survival in seniors
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 patients over 60 receiving a stem cell transplant for blood cancers or bone marrow failure. The plan included tailored changes to diet, sleep, activity, and medications. The goal was to see if these changes …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
New combo aims to tame transplant complications in blood cancer
Disease control CompletedThis study tested whether adding an experimental drug (VIC-1911) to standard medications can prevent graft-versus-host disease (GVHD) and relapse in adults with blood cancers like leukemia or lymphoma who receive a stem cell transplant. Sixteen participants were enrolled. The goa…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
New drug combo may reduce deadly transplant complication in blood cancer patients
Disease control CompletedThis study looked at 174 adults with blood cancers who received a stem cell transplant from an unrelated donor. Researchers compared different combinations of immune-suppressing drugs to find the best way to prevent graft-versus-host disease (GVHD), a serious complication where d…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:33 UTC
-
Half-Matched donor transplant offers hope for blood cancer patients
Disease control CompletedThis study tested a less intense stem cell transplant for people with various blood cancers who are older or have other health issues. It used a half-matched family donor (like a parent or sibling) and a milder chemo and radiation preparation. The goal was to see how many patient…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Blood cancer patients face higher clot risk from COVID
Knowledge-focused CompletedThis study looked at 552 adults with myeloproliferative neoplasms (MPN), a type of blood cancer, who also got COVID-19. Researchers wanted to see how often these patients developed dangerous blood clots, like pulmonary embolism. The goal was to understand what factors make COVID-…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC